These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33239998)

  • 1. Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine.
    Nowicki RJ; Trzeciak M; Rudnicka L; Szepietowski J; Kulus M; Kupczyk M; Mastalerz-Migas A; Peregud-Pogorzelski J; Jahnz-Różyk K; Narbutt J; Czarnecka-Operacz M; Czajkowski R; Grubska-Suchanek E; Krasowska D; Kręcisz B; Kowalewski C; Lesiak A; Olszewska M; Samochocki Z; Śpiewak R; Wilkowska A
    Postepy Dermatol Alergol; 2020 Oct; 37(5):617-624. PubMed ID: 33239998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part I. Prophylaxis, topical treatment and phototherapy.
    Nowicki RJ; Trzeciak M; Kaczmarski M; Wilkowska A; Czarnecka-Operacz M; Kowalewski C; Rudnicka L; Kulus M; Mastalerz-Migas A; Peregud-Pogorzelski J; Sokołowska-Wojdyło M; Śpiewak R; Adamski Z; Czuwara J; Kapińska-Mrowiecka M; Kaszuba A; Krasowska D; Krêcisz B; Narbutt J; Majewski S; Reich A; Samochocki Z; Szepietowski J; Woźniak K
    Postepy Dermatol Alergol; 2020 Feb; 37(1):1-10. PubMed ID: 32467676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atopic dermatitis. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society, Polish Society of Allergology, Polish Pediatric Society and Polish Society of Family Medicine. Part II. Systemic treatment and new therapeutic methods.
    Nowicki RJ; Trzeciak M; Kaczmarski M; Wilkowska A; Czarnecka-Operacz M; Kowalewski C; Rudnicka L; Kulus M; Mastalerz-Migas A; Peregud-Pogorzelski J; Sokołowska-Wojdyło M; Śpiewak R; Adamski Z; Czuwara J; Kapińska-Mrowiecka M; Kaszuba A; Krasowska D; Kręcisz B; Narbutt J; Majewski S; Reich A; Samochocki Z; Szepietowski J; Woźniak K
    Postepy Dermatol Alergol; 2020 Apr; 37(2):129-134. PubMed ID: 32489345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.
    Nowicki R; Trzeciak M; Wilkowska A; Sokołowska-Wojdyło M; Ługowska-Umer H; Barańska-Rybak W; Kaczmarski M; Kowalewski C; Kruszewski J; Maj J; Silny W; Śpiewak R; Petranyuk A
    Postepy Dermatol Alergol; 2015 Aug; 32(4):239-49. PubMed ID: 26366146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP).
    Galli E; Fortina AB; Ricci G; Maiello N; Neri I; Baldo E; Berti I; Bonamonte D; Capra L; Carboni E; Carello R; Caroppo F; Cavagni G; Chinellato I; Cipriani F; Comberiati P; Diociaiuti A; Di Lernia V; Duse M; Filippeschi C; Giannetti A; Giovannini M; Licari A; Marseglia GL; Pace M; Patrizi A; Pajno GB; Peroni D; Villani A; Eichenfield L
    Ital J Pediatr; 2022 Jun; 48(1):95. PubMed ID: 35701810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
    Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.
    Werfel T; Heratizadeh A; Aberer W; Augustin M; Biedermann T; Bauer A; Fölster-Holst R; Kahle J; Kinberger M; Nemat K; Neustädter I; Peters E; von Kiedrowski R; Schmid-Grendelmeier P; Schmitt J; Schwennesen T; Simon D; Spindler T; Traidl-Hoffmann C; Werner RN; Wollenberg A; Worm M; Ott H
    J Dtsch Dermatol Ges; 2024 Jan; 22(1):137-153. PubMed ID: 38171719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kraft M; Worm M
    Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atopic dermatitis of the adult].
    Hello M; Aubert H; Bernier C; Néel A; Barbarot S
    Rev Med Interne; 2016 Feb; 37(2):91-9. PubMed ID: 26617291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctivitis in patients with atopic dermatitis treated with dupilumab.
    Ferreira S; Torres T
    Drugs Context; 2020; 9():. PubMed ID: 32426016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy.
    Ariëns LFM; Bakker DS; van der Schaft J; Garritsen FM; Thijs JL; de Bruin-Weller MS
    Ther Adv Chronic Dis; 2018 Sep; 9(9):159-170. PubMed ID: 30181845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs for atopic dermatitis.
    Hon KL; Leung AKC; Leung TNH; Lee VWY
    Expert Opin Investig Drugs; 2018 Aug; 27(8):637-647. PubMed ID: 30058384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
    D'Erme AM; Romanelli M; Chiricozzi A
    Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.